A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...

A recent trial evaluates the impact of dostarlimab on ovarian cancer treatment, revealing modest benefits and no significant safety concerns with niraparib.

Scientists are hoping to treat diseases including cancer and Alzheimer's by influencing how cells make life-or-death decisions.

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not ...

Rosnilimab acts as an agonist to stimulate PD-1, killing those cells with high PD-1 expression and pushing others into an ...

(A) The Incucyte® Apoptosis Assay allows automated imaging and quantitative analysis of every well of a 96/384-well plate, ...

New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer.

Loqtorzi significantly improved progression-free and overall survival in HER2-expressing advanced urothelial carcinoma compared to chemotherapy. The study demonstrated a higher overall response rate ...

UTA doctoral student Rashna Sharmin's discovery could help scientists better understand brain development and disease. (UTA ...